ImmuPharma up; 8p Lanstead test in focus for cash runway
ImmuPharma plc moved higher Monday, but the bigger question for investors is if shares can get near 8p, which is the level needed for the company’s Lanstead funding plan to pan out as expected. IMM traded at 3.745p, with a 3.50p bid and 3.995p ask. The market cap was £23.37 million on 623.91 million shares outstanding. Fidelity posted a 16:35 BST price, showing the stock up 0.27p, or 7.77%. On the same page, the FTSE All-Share was off 0.24%. The most recent press release in Fidelity’s feed was still the June 25 annual general meeting result, so nothing in Monday’s price action was tied to a new Monday filing there.